Bioscience

Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies

Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies

BOULDER -- Biodesix, Inc . announced it has collaborated with California-based Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies... Read More

Wednesday May 20, 2020 0 comments Tags: Boulder, Biodesix, Scott Hutton, COVID-19, Bio-Rad labs

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

GOLDEN -- PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova... Read More

Wednesday May 20, 2020 0 comments Tags: Golden, PharmaJet, Abnova, Chris Cappello, COVID-19

Looking to the future of healthcare technology

Looking to the future of healthcare technology

For InnovatioNews COLORADO -- The world of healthcare technology is thriving. In fact, a 2018 report on Mobile Health News found that the top 61 health tech companies in the U.S. had profits... Read More

Tuesday May 19, 2020 0 comments

ArcherDX receives FDA breakthrough device designation to detect NTRK gene fusions in cancer

ArcherDX receives FDA breakthrough device designation to detect NTRK gene fusions in cancer

BOULDER -- ArcherDX, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as... Read More

Tuesday May 19, 2020 0 comments

Cerapedics announces results from clinical trial of i-FACTOR® Peptide Enhanced Bone Graft in lumbar fusion surgery

Cerapedics announces results from clinical trial of i-FACTOR® Peptide Enhanced Bone Graft in lumbar fusion surgery

WESTMINSTER -- Cerapedics , a private ortho-biologics company, today announced results from a clinical trial evaluating i-FACTOR Peptide Enhanced Bone Graft in non-instrumented lumbar fusion surgery... Read More

Tuesday May 19, 2020 0 comments

Clovis: Rubraca approved in U.S. for treatment of BRCA1/2-Mutant, metastatic castration-resistant prostate cancer

Clovis: Rubraca approved in U.S. for treatment of BRCA1/2-Mutant, metastatic castration-resistant prostate cancer

BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the U.S. Food and Drug Administration (FDA) approved Rubraca ® (rucaparib) tablets for the treatment of adult patients with a... Read More

Monday May 18, 2020 0 comments Tags: Boulder, Clovis Oncology, Rubraca, Patrick J. Mahaffy

ArcherDX and Bayer announce global collaboration to develop next-gen sequencing-based companion diagnostic for VITRAKVI

ArcherDX and Bayer announce global collaboration to develop next-gen sequencing-based companion diagnostic for VITRAKVI

BOULDER/BERLIN -- ArcherDX and Bayer today announced a global collaboration for the development and commercialization of a next-generation sequencing (NGS)-based companion diagnostic (CDx) for... Read More

Thursday May 14, 2020 0 comments Tags: Boulder, ArcherDx, Jason Myers, Bayer

CSU: Poxviruses could yield protein pathways for coronavirus vaccine

CSU: Poxviruses could yield protein pathways for coronavirus vaccine

FORT COLLINS -- A vaccine first introduced in the late 1700s could help researchers today looking for a way to fight the coronavirus. Dr. Amy MacNeill, a veterinary pathologist... Read More

Tuesday May 12, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, Amy MacNeill, Laura Ashton